Clinical Trials Browser

Has results × Gliosarcoma × pembrolizumab × Clear all

NCT02337686 2025-08-15

Pembrolizumab in Treating Patients With Recurrent Glioblastoma

Phase 2 Active not recruiting

18 enrolled 12 charts

Glioblastoma, Gliosarcoma